Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Which? Hunt – Industry Blasts Investigation Claiming That Supplements Sold In UK ‘Don’t Contain What They Say’

Executive Summary

"The amount of the vitamins in the bottle didn’t match what’s listed on the packaging," said consumer group Which? after carrying out testing on a number of popular supplements. Branding the results "misleading", the manufacturers argue Which?'s methodology was "flawed" and its testing methods "not suitable."

You may also be interested in...



Supplement Firms Face Spiralling Costs And Serious Disruption In Event Of No Deal Brexit

Labelling costs approaching £1.0m, import and export delays, and higher consumer prices are some of the many issues facing the food supplements industry in the event of a no deal Brexit, trade association CRN UK tells HBW Insight.

Vegan Trend Propelling Growth of UK Dietary Supplements Market

Vegans and vegetarians looking to supplement their diet with calcium and iron helped boost overall sales of VMS products in the UK in 2018, according to data from Mintel. Total VMS sales reached £442m in 2018, with the market forecast to grow by 8% over the next five years.

Marinomed Takes Virus-Blocking Device Into Allergy And Dry Eye Categories

Virus-blocking compound Carragelose, out-licensed to major consumer health players such as Perrigo and Reckitt for use in OTC respiratory nasal sprays, is being adapted for use in the dry eye and allergy categories.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148676

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel